The Conolidine Diaries
Our profiling and comparison on the actions of conolidine and cannabidiol with acknowledged pharmacological agents predicted a MOA shared with Cav2.2 channel blocker, ω-conotoxin CVIE.2020). ACKR3 functions as being a 'scavenger' that 'traps' the secreted opioids and stops them from binding on the classical receptors, therefore dampening their ana